Comparative sensitivities of Sabin and Mahoney poliovirus type 1 prototype strains and two recent isolates to low concentrations of glutaraldehyde

Applied and Environmental Microbiology

Volumn 63, Issue 8, 1997, Pages 3199-3204

  Chambon, Martine ^a   Jallat Archimbaud, Christine ^a   Bailly, Jean Luc ^a   Gourgand, Jeanne Marie ^b   Charbonne, Françoise ^a   Henquell, Cécile ^a   Fuchs, Florence ^c   Peigue Lafeuille, Hélène ^a  

^a Laboratoire de Biologie et d'Immunologie (BlOLIM)   (France)

^b UNIVERSITÉ BLAISE PASCAL   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTARALDEHYDE;

ARTICLE; NONHUMAN; POLIOMYELITIS VIRUS; VIRUS INACTIVATION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS TYPING;

ECHOVIRUS; HUMAN POLIOVIRUS 1; MIRIDAE; POLIOVIRUS;

EID: 0030803905     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.63.8.3199-3204.1997     Document Type: Article

References (25)

1. Bailly, J. L., M. Chambon, H. Peigue-Lafeuille, H. Laveran, C. De Champs, and D. Beytout. 1991. Activity of glutaraldehyde at low concentrations (<2%) against poliovirus and its relevance to gastrointestinal endoscope disinfection procedures. Appl. Environ. Microbiol. 57:1156-1160.
2. Bailly, J. L., A. M. Borman, H. Peigue-Lafeuille, and K. M. Kean. 1996. Natural isolates of echovirus type 25 with extensive variations in IRES sequences and different translational efficiencies. Virology 215:83-96.
3. Balanant, J., S. Guillot, A. Candrea, F. Delepyroux, and R. Crainic. 1991. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 184:645-654.
4. Bloomfield, S. F., and E. Looney. 1992. Evaluation of the repeatability and reproducibility of European suspension test methods for antimicrobial activity of disinfectants and antiseptics. J. Appl. Bacteriol. 73:87-93.
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Chambon, M., J. L. Bailly, and H. Peigue-Lafeuille. 1992. Activity of glutaraldehyde at low concentrations against capsid proteins of poliovirus type 1 and echovirus type 25. Appl. Environ. Microbiol. 58:3517-3521.
7. Chambon, M., J.-L. Bailly, and H. Peigue-Lafeuille. 1994. Comparative sensitivity of the echovirus type 25 JV-4 prototype strain and two recent isolates to glutaraldehyde at low concentrations. Appl. Environ. Microbiol. 60:387-392.
8. Crainic, R., P. Couillin, B. Blondel, N. Cabau, A. Boue, and F. Horodniceanu. 1983. Natural variation of poliovirus neutralization epitopes. Infect. Immun. 41:1217-1225.
9. Hogle, J. M., M. Chow, and D. J. Filman. 1985. Three-dimensional structure of poliovirus at 2.9 Å resolution. Science 229:1358-1365.
10. Huovilainen, A., L. Kinnunen, T. Pöyry, L. Laaksonen, M. Roivainen, and T. Hovi. 1994. Poliovirus type 3/Saukett: antigenic and structural correlates of sequence variation in the capsid proteins. Virology 199:228-232.
11. Kew, O. M., B. K. Nottay, M. H. Hatch, J. H. Nakano, and J. F. Obijeski. 1981. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J. Gen. Virol. 56:337-347.
12. Kirkwood, C. D., M. L. Kennett, and R. D. Schnagl. 1988. Neutralization kinetic analysis showed that strains of echovirus type 7, 11 and 17, unlike those of echovirus type 30, varied antigenically over time in Melbourne, Australia. Acta Virol. 32:267-271.
13. Korn, A. H., S. H. Feairheller, and E. M. Filachione. 1972. Glutaraldehyde: nature of the reagent. J. Mol. Biol. 65:525-529.
14. Lipskaya, G. Y., E. A. Chervonskaya, G. I. Belova, S. V. Maslova, T. N. Kutateladze, S. G. Drozdov, M. Mulders, M. A. Pallansch, O. M. Kew, and V. I. Agol. 1995. Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes. J. Gen. Virol. 76:1687-1699.
15. Lwoff, A. 1959. Factors influencing the evolution of viral diseases at the cellular level in the organism. Bacteriol. Rev. 23:109-124.
16. Minor, P. D., G. C. Schild, M. Ferguson, A. Mackay, D. I. Magrath, A. John, P. J. Yates, and M. Spitz. 1982. Genetic and antigenic variation in type 3 polioviruses: characterization of strains by monoclonal antibodies and T1 oligonucleotide mapping. J. Gen. Virol. 61:167-176.
17. Minor, P. D., A. John, M. Ferguson, and J. P. Icenogle. 1986. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccine. J. Gen. Virol. 67:693-706.
18. Minor, P. D. 1990. Antigenic structure of picornaviruses. Curr. Top. Microbiol. Immunol. 161:122-154.
19. O'Neill, K. M., M. A. Pallansch, J. A. Winkelstein, T. M. Lock, and J. F. Modlin. 1988. Chronic group A coxsackievirus infection in agammaglobulinemia: demonstration of genomic variation of serotypically identical isolates persistently excreted by the same patient. J. Infect. Dis. 157:185-186.
20. Page, G. S., A. G. Mosser, J. M. Hogle, D. J. Filman, R. R. Rueckert, and M. Chow. 1988. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J. Virol. 62:1781-1794.
21. Peigue-Lafeuille, H., F. Fuchs, F. Gharabaghi, M. Chambon, and M. Aymard. 1990. Impact on routine diagnosis of echovirus infections of intratypic differentiation and antigenic variation in echovirus type 25 studied by using monoclonal antibodies. J. Clin. Microbiol. 28:2291-2296.
22. Prabhakar, B. S., M. V. Haspel, P. R. McClintock, and A. L. Notkins. 1982. High frequency of antigenic variants among naturally occurring human coxsackie B4 virus isolates identified by monoclonal antibodies. Nature (London) 300:374-376.
23. Toyoda, H., M. Kohara, Y. Kastaoka, T. Suganuma, M. Imura, and A. Nomoto. 1984. Complete nucleotide sequence of all three poliovirus serotype genomes: implications for genetic relationship, gene function and antigenic determinants. J. Mol. Biol. 124:561-595.
24. Vanden Bossche, G., U. Wustmann, and S. Krietemeyer. 1994. Ozone disinfection dynamics of enteric viruses provide evidence that infectious titer reduction is triggered by alterations to viral colloidal properties. Microbiol. Res. 149:351-370.
25. Young, D. C., and D. G. Sharp. 1985. Virion conformational forms and the complex inactivation kinetics of echovirus by chlorine in water. Appl. Environ. Microbiol. 49:359-364.